Actively Recruiting

All Genders
NCT07481526

A Prospecitve Multicenter, Observational Registry Study

Led by AstraZeneca · Updated on 2026-05-12

3000

Participants Needed

1

Research Sites

148 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective, multicenter, observational registry study designed to collect data to deepen the understanding of CKD therapeutics, changes in clinical practice, cardiorenal risk outcomes and differences in treatment approaches in Chinese CKD patients.

CONDITIONS

Official Title

A Prospecitve Multicenter, Observational Registry Study

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female patients aged �3E= 18 years
  • Willing and able to provide written informed consent to participate in the study
  • Confirmed chronic kidney disease diagnosis at enrollment, defined by either:
  • eGFR less than 60 mL/min/1.73 m�b2 for 3 months or more
  • Evidence of kidney damage such as urine albumin-to-creatinine ratio (UACR) �3E= 30 mg/g, urine protein-to-creatinine ratio (UPCR) �3E= 150 mg/g, structural abnormalities on imaging, or kidney biopsy findings consistent with chronic kidney injury persisting for 3 months or more
Not Eligible

You will not qualify if you...

  • Life-threatening comorbidity with life expectancy less than 2 years
  • Severe cardiac disease including life-threatening arrhythmias or recent major adverse cardiovascular events (MI, stroke, cardiovascular death) within the past 3 months
  • Pregnant or breastfeeding women
  • Currently enrolled in any interventional clinical trial or receiving investigational therapy within 3 months of enrollment
  • Presenting with end-stage renal disease (ESRD), receiving renal replacement therapy (RRT), acute kidney injury (AKI), or acute kidney disease as a primary condition at enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zhongshan Hospital Affilicated with Fudan University

Shanghai, China

Actively Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here